Foscavir Articles
US jury finds in favor of AstraZeneca in Seroquel product liability case; Clinigen takes over Foscavir
19 March 2010
New CPAC Approvals Include Two NCEs
7 April 1997
Antivirals "Now 9% Of Anti-Infectives Market"
11 March 1996
New Indication For Astra's Foscavir
17 July 1995
First Results With Gilead's AIDS Treatment
8 May 1995
Gilead's New Products Add To Impressive Pipeline
6 March 1995
Isis Begins Phase III CMV Retinitis Trials
2 January 1995
KIDDER, PEABODY ON BIOTECHNOLOGY
2 May 1994
FOSCAVIR MAINTENANCE
24 January 1994
INCREASE IN NEW AIDS drugs IN TRIALS IN USA FOR 1993
10 January 1994
SINGAPORE CHARITY BUYS AIDS DRUGS
20 September 1993
NEW YORK BOYCOTT FOR ASTRA
21 June 1993
PROTEIN DESIGN LABS NEW REGIMEN
21 June 1993
PRETAX AND EPS SOAR AT ASTRA IN 1992
1 March 1993
SUPPLEMENTAL NDA FOR FOSCAVIR
7 December 1992
ASTRA TO FUND CMV TREATMENT STUDY
25 May 1992
DRUG COST DILEMMA FOR ASTRA
27 January 1992
Showing 1-17 of 17 articles
- 1
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
